10:07 AM EST - Ondine Biopharma Corp. : says the U.S. Food and Drug Administration has announced premarket classification for its submission on the Periowave photo-disinfection system for dentistry. An FDA branch classified the device as Class 3, an automatic designation since no substantially equivalent system has been sold previously. Ondine Biopharma Corp.
shares T.OBP are trading unchanged at $0.90.
